Portuguese-Speaking African Countries (PSAC)
Cross-source consensus on Portuguese-Speaking African Countries (PSAC) from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Evidence quality
Where it comes from
Highlighted claims
- The five PSAC—Angola, Cabo Verde, Guinea-Bissau, São Tomé and Príncipe, and Mozambique—share cultural identity, linguistic ties, and regulatory similarities, forming a coherent cluster for clinical research analysis. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- PSAC together represent over 73 million people across an area exceeding 2 million square kilometres. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- PSAC have never been the subject of a comprehensive scoping review examining their clinical trial landscape. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- A preliminary search across major databases and registries confirmed no current or ongoing scoping or systematic review on clinical trials in PSAC exists. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol
- Three targeted projects—BERC-Luso, CT-Luso, and LusoAfroBioEthics—have begun addressing gaps in ethical review capacity and regulatory infrastructure in PSAC, but their coverage remains limited. — Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol